SEC Form 4 · accession 0001179110-18-009888
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alejandro D Wellisch
Officer — Senior Vice President
Period of report
Jul 21, 2018
Accepted (ET)
Jul 24, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Jul 21, 2018 | A | 1,498 | $0.00 | A | 9,591 | D | |
| Common shares without par value | Jul 21, 2018 | F | 525 | $63.32 | D | 9,066 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.